CIK 0001501796
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320271970
- Phone
- +1 617-500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Medical Officer sold 16,903 shares at $7.05 ($119,166)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Grant or award Chief People Officer acquired 107,611 shares (grant or award)
- 4 Grant or award Chief Reg. & Quality Officer acquired 100,885 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 58,850 shares (grant or award)
- 4 Grant or award SVP, Finance & PAO acquired 23,540 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 134,513 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 1 of 20 · 388 filings